Altimmune, Inc. — Director's Dealing 2019

Dec 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2019-11-30

Reporting Person: Garg Vipin K (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-30	Common Stock, par value $0.0001	F	23976	$1.82	Disposed	318931	Direct

Footnotes

F1: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock.